Metaxalone Tablet
FDA Label NDC 68001-485

25 label sections · Submitted to the FDA by Bluepoint Laboratories · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bluepoint Laboratories for the product Metaxalone (NDC 68001-485). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 3 dosage forms and strengths, 4 contraindications, 5.1 serotonin syndrome, 5.2 central nervous system depression, 6 adverse reactions, 7.1 serotonergic drugs, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Principal Display Panel

NDC 68001-485-00

This container is not intended for household use.

Metaxalone
Tablets, USP

800 mg

Rx only

100 Tablets

SEALED FOR YOUR PROTECTION

BluePoint Laboratories

Metaxalone 800mg Label (Metaxalone 800mg 100tab)

Metaxalone 800mg Label (Metaxalone 800mg 100tab)

* Please review the disclaimer below.